| Dr Elizabeth Ann Kulesza, MD | |
|
7 Stem Brook Rd, Montvale, NJ 07645-1231 | |
| (201) 476-0196 | |
| Not Available |
| Full Name | Dr Elizabeth Ann Kulesza |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 7 Stem Brook Rd, Montvale, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043236466 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 00185248 (New York) | Primary |
| Entity Name | Premier Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760436190 PECOS PAC ID: 1254233158 Enrollment ID: O20040122000144 |
News Archive
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, today announced that it received a letter from NASDAQ on July 8, 2010, stating that a NASDAQ Hearings Panel granted the Company's request for an extension of time, as permitted under NASDAQ's Listing Rules, to regain compliance with the $2.5 million minimum stockholders' equity requirement for continued listing on the NASDAQ Stock Market.
Resverlogix Corp. announced today that results from the Company's Phase 1b/2a clinical trial have met and exceeded expectations by successfully concluding the drug, RVX-208, is safe and tolerable. Most importantly RVX-208 has met its primary endpoint to increase the production of plasma ApoA-I, the key cardioprotective protein in high-density lipoprotein (HDL), often referred to as "good" cholesterol.
Parkinson's disease is a neurodegenerative disorder that presents clinically with abnormal movement and tremors at rest.
Since 1999, stroke survivors have been advised to use aspirin, prescription antiplatelet agents, or prescription anticoagulants to help avoid another stroke. Many large surveys of the U.S. population have reported the use of aspirin for secondary prevention, but commonly combine people with stroke and coronary artery disease, and only rarely report the use of antithrombotic agents other than aspirin.
Pediatric plastic surgeon Rohit Khosla, MD, had never seen a case like it: the 12-year-old boy's face ballooned with a rare, aggressive bone tumor. Although it was non-cancerous, the tumor was destroying the patient's jaw. Khosla knew he would need an innovative approach to save the boy's ability to chew.
› Verified 3 days ago
| Entity Name | Ks Medical, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295131506 PECOS PAC ID: 7618291683 Enrollment ID: O20150122000241 |
News Archive
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, today announced that it received a letter from NASDAQ on July 8, 2010, stating that a NASDAQ Hearings Panel granted the Company's request for an extension of time, as permitted under NASDAQ's Listing Rules, to regain compliance with the $2.5 million minimum stockholders' equity requirement for continued listing on the NASDAQ Stock Market.
Resverlogix Corp. announced today that results from the Company's Phase 1b/2a clinical trial have met and exceeded expectations by successfully concluding the drug, RVX-208, is safe and tolerable. Most importantly RVX-208 has met its primary endpoint to increase the production of plasma ApoA-I, the key cardioprotective protein in high-density lipoprotein (HDL), often referred to as "good" cholesterol.
Parkinson's disease is a neurodegenerative disorder that presents clinically with abnormal movement and tremors at rest.
Since 1999, stroke survivors have been advised to use aspirin, prescription antiplatelet agents, or prescription anticoagulants to help avoid another stroke. Many large surveys of the U.S. population have reported the use of aspirin for secondary prevention, but commonly combine people with stroke and coronary artery disease, and only rarely report the use of antithrombotic agents other than aspirin.
Pediatric plastic surgeon Rohit Khosla, MD, had never seen a case like it: the 12-year-old boy's face ballooned with a rare, aggressive bone tumor. Although it was non-cancerous, the tumor was destroying the patient's jaw. Khosla knew he would need an innovative approach to save the boy's ability to chew.
› Verified 3 days ago
| Entity Name | Wellcare Of Bx Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851848618 PECOS PAC ID: 5890040166 Enrollment ID: O20180611001867 |
News Archive
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, today announced that it received a letter from NASDAQ on July 8, 2010, stating that a NASDAQ Hearings Panel granted the Company's request for an extension of time, as permitted under NASDAQ's Listing Rules, to regain compliance with the $2.5 million minimum stockholders' equity requirement for continued listing on the NASDAQ Stock Market.
Resverlogix Corp. announced today that results from the Company's Phase 1b/2a clinical trial have met and exceeded expectations by successfully concluding the drug, RVX-208, is safe and tolerable. Most importantly RVX-208 has met its primary endpoint to increase the production of plasma ApoA-I, the key cardioprotective protein in high-density lipoprotein (HDL), often referred to as "good" cholesterol.
Parkinson's disease is a neurodegenerative disorder that presents clinically with abnormal movement and tremors at rest.
Since 1999, stroke survivors have been advised to use aspirin, prescription antiplatelet agents, or prescription anticoagulants to help avoid another stroke. Many large surveys of the U.S. population have reported the use of aspirin for secondary prevention, but commonly combine people with stroke and coronary artery disease, and only rarely report the use of antithrombotic agents other than aspirin.
Pediatric plastic surgeon Rohit Khosla, MD, had never seen a case like it: the 12-year-old boy's face ballooned with a rare, aggressive bone tumor. Although it was non-cancerous, the tumor was destroying the patient's jaw. Khosla knew he would need an innovative approach to save the boy's ability to chew.
› Verified 3 days ago
| Entity Name | Urban Medical Services Of Bx Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235845009 PECOS PAC ID: 4688028772 Enrollment ID: O20230922002174 |
News Archive
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, today announced that it received a letter from NASDAQ on July 8, 2010, stating that a NASDAQ Hearings Panel granted the Company's request for an extension of time, as permitted under NASDAQ's Listing Rules, to regain compliance with the $2.5 million minimum stockholders' equity requirement for continued listing on the NASDAQ Stock Market.
Resverlogix Corp. announced today that results from the Company's Phase 1b/2a clinical trial have met and exceeded expectations by successfully concluding the drug, RVX-208, is safe and tolerable. Most importantly RVX-208 has met its primary endpoint to increase the production of plasma ApoA-I, the key cardioprotective protein in high-density lipoprotein (HDL), often referred to as "good" cholesterol.
Parkinson's disease is a neurodegenerative disorder that presents clinically with abnormal movement and tremors at rest.
Since 1999, stroke survivors have been advised to use aspirin, prescription antiplatelet agents, or prescription anticoagulants to help avoid another stroke. Many large surveys of the U.S. population have reported the use of aspirin for secondary prevention, but commonly combine people with stroke and coronary artery disease, and only rarely report the use of antithrombotic agents other than aspirin.
Pediatric plastic surgeon Rohit Khosla, MD, had never seen a case like it: the 12-year-old boy's face ballooned with a rare, aggressive bone tumor. Although it was non-cancerous, the tumor was destroying the patient's jaw. Khosla knew he would need an innovative approach to save the boy's ability to chew.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth Ann Kulesza, MD 7 Stem Brook Rd, Montvale, NJ 07645-1231 Ph: (201) 476-0196 | Dr Elizabeth Ann Kulesza, MD 7 Stem Brook Rd, Montvale, NJ 07645-1231 Ph: (201) 476-0196 |
News Archive
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, today announced that it received a letter from NASDAQ on July 8, 2010, stating that a NASDAQ Hearings Panel granted the Company's request for an extension of time, as permitted under NASDAQ's Listing Rules, to regain compliance with the $2.5 million minimum stockholders' equity requirement for continued listing on the NASDAQ Stock Market.
Resverlogix Corp. announced today that results from the Company's Phase 1b/2a clinical trial have met and exceeded expectations by successfully concluding the drug, RVX-208, is safe and tolerable. Most importantly RVX-208 has met its primary endpoint to increase the production of plasma ApoA-I, the key cardioprotective protein in high-density lipoprotein (HDL), often referred to as "good" cholesterol.
Parkinson's disease is a neurodegenerative disorder that presents clinically with abnormal movement and tremors at rest.
Since 1999, stroke survivors have been advised to use aspirin, prescription antiplatelet agents, or prescription anticoagulants to help avoid another stroke. Many large surveys of the U.S. population have reported the use of aspirin for secondary prevention, but commonly combine people with stroke and coronary artery disease, and only rarely report the use of antithrombotic agents other than aspirin.
Pediatric plastic surgeon Rohit Khosla, MD, had never seen a case like it: the 12-year-old boy's face ballooned with a rare, aggressive bone tumor. Although it was non-cancerous, the tumor was destroying the patient's jaw. Khosla knew he would need an innovative approach to save the boy's ability to chew.
› Verified 3 days ago
Dr. Gabriela Wojnarska-alvarez, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 221 W Grand Ave, Suite 105, Montvale, NJ 07645 Phone: 101-746-9333 Fax: 201-746-9335 | |
Dr. Sakina Firoz Dinani, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 W Grand Ave Ste 900, Montvale, NJ 07645 Phone: 201-677-8680 Fax: 888-425-6116 | |
Dr. Rebecca M Varghese, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 E Grand Ave, Montvale, NJ 07645 Phone: 201-775-1153 Fax: 845-675-5005 | |
Ping Gu, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 Summit Avenue, Montvale, NJ 07645 Phone: 201-775-7183 Fax: 201-691-6661 | |
Dr. Anupama Doraiswamy, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 Summit Ave, Montvale, NJ 07645 Phone: 201-775-7000 | |
Dr. Anuja Kriplani, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 Summit Ave, Montvale, NJ 07645 Phone: 201-775-7443 |